Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.45 -0.02 (-4.66%)
As of: Nov 16, 2026 · 3:48 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Income from Continuing Operations (2009 - 2026)

Updated

Protagenic Therapeutics, Inc.new's Income from Continuing Operations was -$667,194 in fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$869,496 a year earlier.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Income from Continuing Operations (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Protagenic Therapeutics, Inc.new's Income from Continuing Operations was $5.66 million through Sep 30, 2026; for FY2026 (ended Mar 31, 2026), it came in at $1.37 million.

  • In earlier fiscal years, Income from Continuing Operations was -$3.59 million in FY2025, -$5.53 million in FY2024, -$5 million in FY2023 and -$3.56 million in FY2022.
  • Quarterly Income from Continuing Operations has moved between -$5.06 million (fiscal Q1 2026) and $5.08 million (fiscal Q4 2026) over five years.
  • Per Business Quant data, PTIX's Income from Continuing Operations in the three fiscal quarters before Q2 2027 was -$963,616 (Q1 2027), $5.08 million (Q4 2026) and $2.21 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 210.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.22 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.80 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.25 Bn
10 Protagenic Therapeutics, Inc.new 850,797.76 -4.70 Mn - -667,194.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -667,194.00
Jun 30, 2026 -963,616.00
Mar 31, 2026 5.08 Mn
Dec 31, 2025 2.21 Mn
Sep 30, 2025 -869,496.00
Jun 30, 2025 -5.06 Mn
Mar 31, 2025 -1.44 Mn
Dec 31, 2024 -850,287.00
Sep 30, 2024 -582,387.00
Jun 30, 2024 -1.61 Mn
Mar 31, 2024 -1.72 Mn
Dec 31, 2023 -1.68 Mn
Sep 30, 2023 -1.40 Mn
Jun 30, 2023 -1.21 Mn
Mar 31, 2023 -718,096.00
Dec 31, 2022 -601,374.00
Sep 30, 2022 -925,305.00
Jun 30, 2022 -666,717.00
Mar 31, 2022 -1.36 Mn
Dec 31, 2021 -890,387.00
API Access

Protagenic Therapeutics, Inc.new Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=PTIX&period=max&api_key=YOUR_API_KEY